Cargando…

Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up

BACKGROUND: Chronic hepatitis B (CHB) is a dynamic disease that may be affected by immune changes in pregnancy. Guidelines suggest consideration of nucleos/tide analogs (NA), i.e., tenofovir, (TDF) in highly viremic mothers to reduce vertical transmission risk. HBV variability affects CHB outcome, b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Virine, Boris, Osiowy, Carla, Gao, Shan, Wang, Tong, Castillo, Eliana, Martin, Steven R., Lee, Samuel S., Simmonds, Kimberley, van Marle, Guido, Coffin, Carla S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608582/ https://www.ncbi.nlm.nih.gov/pubmed/26474400 http://dx.doi.org/10.1371/journal.pone.0140070

Ejemplares similares

Correction: Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients During Pregnancy and Post-Partum Follow-up
por: Virine, Boris, et al.
Publicado: (2015)

Hepatitis B vaccination for Canadian children: time for an adult conversation
por: Coffin, Carla S., et al.
Publicado: (2021)

From infancy and beyond… ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity
por: Osiowy, Carla
Publicado: (2018)

Chronic hepatitis B carriers with acute on chronic liver failure show increased HBV surface gene mutations, including immune escape variants
por: Gao, Shan, et al.
Publicado: (2017)

Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)
por: Coffin, Carla S., et al.
Publicado: (2022)

Review of Laboratory Tests used in Monitoring Hepatitis B Response to Pegylated Interferon and Nucleos(t)ide Analog Therapy
por: Osiowy, Carla, et al.
Publicado: (2016)

Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals
por: Lee, Z., et al.
Publicado: (2015)

Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management
por: Vachon, Alicia, et al.
Publicado: (2021)

Hepatitis B virus serum RNA transcript isoform composition and proportion in chronic hepatitis B patients by nanopore long-read sequencing
por: Vachon, Alicia, et al.
Publicado: (2023)

Differences in HBV Replication, APOBEC3 Family Expression, and Inflammatory Cytokine Levels Between Wild-Type HBV and Pre-core (G1896A) or Basal Core Promoter (A1762T/G1764A) Mutants
por: Lau, Keith C. K., et al.
Publicado: (2020)

Tracing hepatitis B virus (HBV) genotype B5 (formerly B6) evolutionary history in the circumpolar Arctic through phylogeographic modelling
por: Bouckaert, Remco, et al.
Publicado: (2017)

The burden of hepatitis B virus (HBV) infection, genotypes and drug resistance mutations in human immunodeficiency virus-positive patients in Northwest Ethiopia
por: Deressa, Tekalign, et al.
Publicado: (2017)

Comprehensive Analysis of Hepatitis B Virus Promoter Region Mutations
por: Meier-Stephenson, Vanessa, et al.
Publicado: (2018)

Identification and characterization of a G-quadruplex structure in the pre-core promoter region of hepatitis B virus covalently closed circular DNA
por: Meier-Stephenson, Vanessa, et al.
Publicado: (2021)

Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America
por: Ghany, Marc G., et al.
Publicado: (2021)

1591 Hepatitis B outcome in coinfected HIV-HBV individuals in the tenofovir/emtricitabine era
por: Nguyen, Divien, et al.
Publicado: (2014)

Hepatitis B Virus Genotype G: The Odd Cousin of the Family
por: Araujo, Natalia M., et al.
Publicado: (2022)

Hepatitis B Virus Genotype Influence on Virological and Enzymatic Measures over Time—A Retrospective Longitudinal Cohort Study
por: Keeshan, Alexa, et al.
Publicado: (2023)

Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)—will there ever be enough data?
por: Crane, Harry, et al.
Publicado: (2023)

Factors affecting HBV DNA suppression in chronic hepatitis B patients treated with tenofovir disoproxil fumarate
por: Darmadi, Darmadi, et al.
Publicado: (2023)

Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics
por: Joshi, Shivali S., et al.
Publicado: (2020)

Characterization of Acute and Chronic Hepatitis B Virus Genotypes in Canada
por: Osiowy, Carla, et al.
Publicado: (2015)

Annotation dataset of the cardiotocographic recordings constituting the “CTU-CHB intra-partum CTG database”
por: Romagnoli, Sofia, et al.
Publicado: (2020)

Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort study
por: Wang, Tingyan, et al.
Publicado: (2021)

Efficacy Comparison of Tenofovir and Entecavir in HBeAg-Positive Chronic Hepatitis B Patients with High HBV DNA
por: Shi, Hong, et al.
Publicado: (2016)

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
por: Mokaya, Jolynne, et al.
Publicado: (2019)

Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults
por: Mokaya, Jolynne, et al.
Publicado: (2020)

Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis
por: Zhang, Ping, et al.
Publicado: (2018)

Gwen Douglas, MB ChB, FRCPsych
por: Shoenberg, Peter
Publicado: (2022)

Editorial: Origin and Evolution of Hepatitis Viruses
por: Osiowy, Carla, et al.
Publicado: (2021)

Transmission of hepatitis D virus between spouses: A longitudinal study of the first reported Canadian case
por: Osiowy, Carla, et al.
Publicado: (2017)

Tenofovir and its potential in the treatment of hepatitis B virus
por: Reynaud, Laura, et al.
Publicado: (2009)

Systemic cytokine and viral antigen-specific responses in hepatitis D virus RNA positive versus HDV RNA negative patients
por: Joshi, Shivali S., et al.
Publicado: (2023)

Antiviral kinetics of tenofovir alafenamide and tenofovir disoproxil fumarate over 24 weeks in women of childbearing potential with chronic HBV
por: Pan, Calvin Q., et al.
Publicado: (2021)

Peter Sykes MB, ChB, FRCPsych, DPM
por: Savin, Emma
Publicado: (2018)

96-Week Treatment of Tenofovir Amibufenamide and Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients
por: Liu, Zhihong, et al.
Publicado: (2023)

New approaches in the management of chronic hepatitis B: role of tenofovir
por: Reijnders, Jurriën GP, et al.
Publicado: (2009)

Effect of tenofovir on renal function in patients with chronic hepatitis B
por: Jung, Woo Jin, et al.
Publicado: (2018)

HBV quasispecies composition in Lamivudine-failed chronic hepatitis B patients and its influence on virological response to Tenofovir-based rescue therapy
por: Banerjee, Priyanka, et al.
Publicado: (2017)

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
por: Kim, David Sooik, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_msbfpqvmvmo5f612t6p9ptqs9s